Literature DB >> 9679060

The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-beta-induced transcriptional activation.

X H Feng1, Y Zhang, R Y Wu, R Derynck.   

Abstract

Smads regulate transcription of defined genes in response to TGF-beta receptor activation, although the mechanisms of Smad-mediated transcription are not well understood. We demonstrate that the TGF-beta-inducible Smad3 uses the tumor suppressor Smad4/DPC4 and CBP/p300 as transcriptional coactivators, which associate with Smad3 in response to TGF-beta. The association of CBP with Smad3 was localized to the carboxyl terminus of Smad3, which is required for transcriptional activation, and a defined segment in CBP. Furthermore, CBP/p300 stimulated both TGF-beta- and Smad-induced transcription in a Smad4/DPC4-dependent fashion. Smad3 transactivation and TGF-beta-induced transcription were inhibited by expressing E1A, which interferes with CBP functions. The coactivator functions and physical interactions of Smad4 and CBP/p300 with Smad3 allow a model for the induction of gene expression in response to TGF-beta.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9679060      PMCID: PMC317015          DOI: 10.1101/gad.12.14.2153

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  41 in total

1.  Promoter-specific trans-activation by the adenovirus E1A12S product involves separate E1A domains.

Authors:  V B Kraus; E Moran; J R Nevins
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

2.  Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-beta signaling.

Authors:  S Souchelnytskyi; K Tamaki; U Engström; C Wernstedt; P ten Dijke; C H Heldin
Journal:  J Biol Chem       Date:  1997-10-31       Impact factor: 5.157

3.  Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300.

Authors:  A E Horvai; L Xu; E Korzus; G Brard; D Kalafus; T M Mullen; D W Rose; M G Rosenfeld; C K Glass
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

Review 4.  The multifunctional role of the co-activator CBP in transcriptional regulation.

Authors:  P S Goldman; V K Tran; R H Goodman
Journal:  Recent Prog Horm Res       Date:  1997

5.  Receptor-associated Mad homologues synergize as effectors of the TGF-beta response.

Authors:  Y Zhang; X Feng; R We; R Derynck
Journal:  Nature       Date:  1996-09-12       Impact factor: 49.962

6.  A structural basis for mutational inactivation of the tumour suppressor Smad4.

Authors:  Y Shi; A Hata; R S Lo; J Massagué; N P Pavletich
Journal:  Nature       Date:  1997-07-03       Impact factor: 49.962

7.  Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways.

Authors:  G Lagna; A Hata; A Hemmati-Brivanlou; J Massagué
Journal:  Nature       Date:  1996-10-31       Impact factor: 49.962

8.  The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function.

Authors:  Y Zhang; T Musci; R Derynck
Journal:  Curr Biol       Date:  1997-04-01       Impact factor: 10.834

Review 9.  TGF-beta signalling from cell membrane to nucleus through SMAD proteins.

Authors:  C H Heldin; K Miyazono; P ten Dijke
Journal:  Nature       Date:  1997-12-04       Impact factor: 49.962

10.  Transforming growth factor-beta (TGF-beta)-induced down-regulation of cyclin A expression requires a functional TGF-beta receptor complex. Characterization of chimeric and truncated type I and type II receptors.

Authors:  X H Feng; E H Filvaroff; R Derynck
Journal:  J Biol Chem       Date:  1995-10-13       Impact factor: 5.157

View more
  135 in total

1.  Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase.

Authors:  Y Zhang; C Chang; D J Gehling; A Hemmati-Brivanlou; R Derynck
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

Review 2.  Transcriptional control by the TGF-beta/Smad signaling system.

Authors:  J Massagué; D Wotton
Journal:  EMBO J       Date:  2000-04-17       Impact factor: 11.598

3.  A function of CBP as a transcriptional co-activator during Dpp signalling.

Authors:  L Waltzer; M Bienz
Journal:  EMBO J       Date:  1999-03-15       Impact factor: 11.598

4.  A novel smad nuclear interacting protein, SNIP1, suppresses p300-dependent TGF-beta signal transduction.

Authors:  R H Kim; D Wang; M Tsang; J Martin; C Huff; M P de Caestecker; W T Parks; X Meng; R J Lechleider; T Wang; A B Roberts
Journal:  Genes Dev       Date:  2000-07-01       Impact factor: 11.361

5.  TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3.

Authors:  D Liu; B L Black; R Derynck
Journal:  Genes Dev       Date:  2001-11-15       Impact factor: 11.361

6.  Swift is a novel BRCT domain coactivator of Smad2 in transforming growth factor beta signaling.

Authors:  K Shimizu; P Y Bourillot; S J Nielsen; A M Zorn; J B Gurdon
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

7.  Repression of transforming-growth-factor-beta-mediated transcription by nuclear factor kappaB.

Authors:  R P Nagarajan; F Chen; W Li; E Vig; M A Harrington; H Nakshatri; Y Chen
Journal:  Biochem J       Date:  2000-06-15       Impact factor: 3.857

8.  Tissue- and stage-specific modulation of Wingless signaling by the segment polarity gene lines.

Authors:  V Hatini; P Bokor; R Goto-Mandeville; S DiNardo
Journal:  Genes Dev       Date:  2000-06-01       Impact factor: 11.361

Review 9.  TGF-β1 → SMAD/p53/USF2 → PAI-1 transcriptional axis in ureteral obstruction-induced renal fibrosis.

Authors:  Rohan Samarakoon; Jessica M Overstreet; Stephen P Higgins; Paul J Higgins
Journal:  Cell Tissue Res       Date:  2011-06-04       Impact factor: 5.249

10.  Zinc finger protein 451 is a novel Smad corepressor in transforming growth factor-β signaling.

Authors:  Yili Feng; Hongxing Wu; Yongxian Xu; Zhengmao Zhang; Ting Liu; Xia Lin; Xin-Hua Feng
Journal:  J Biol Chem       Date:  2013-12-09       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.